Phase 2 Colorectal Cancer Trial, Recruiting (NCT06949098)

Phase 2 Colorectal Cancer Trial, Recruiting NCT06949098 Sponsor: Hebei Medical University Fourth Hospital Condition: Colorectal Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT06949098 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Colorectal Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are 18 years old or older
You are generally well and able to carry out daily activities with little or no limitation (confirm with trial site)
You have been diagnosed with rectal cancer confirmed by a tissue sample (biopsy)
Your tumor is located in the lower part of the rectum, close to the anal opening (within about 8 cm)
Your cancer is at an early stage and has not spread to nearby lymph nodes or other parts of the body
You strongly prefer to keep your bowel and have declined a major surgery that would require a permanent colostomy bag
A surgeon has confirmed that a smaller, local removal of the tumor is possible
You are able to receive a combination of chemotherapy and radiation treatment without medical concerns

Who may not be able to join:

People who do not meet the requirements listed above
People who are not willing to sign a consent form agreeing to take part in the study
People who have difficulty with thinking, memory, or have a mental health condition that may affect their ability to participate
People who the study doctors decide are not suitable for the trial for other medical reasons (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 2 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06949098

Sponsor: Hebei Medical University Fourth Hospital

Phase: Phase 2

Status: Recruiting

Condition: Colorectal Cancer

More information: https://clinicaltrials.gov/study/NCT06949098

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are 18 years old or older
You are generally well and able to carry out daily activities with little or no limitation (confirm with trial site)
You have been diagnosed with rectal cancer confirmed by a tissue sample (biopsy)
Your tumor is located in the lower part of the rectum, close to the anal opening (within about 8 cm)
Your cancer is at an early stage and has not spread to nearby lymph nodes or other parts of the body
You strongly prefer to keep your bowel and have declined a major surgery that would require a permanent colostomy bag
A surgeon has confirmed that a smaller, local removal of the tumor is possible
You are able to receive a combination of chemotherapy and radiation treatment without medical concerns

Who may not be able to join:

People who do not meet the requirements listed above
People who are not willing to sign a consent form agreeing to take part in the study
People who have difficulty with thinking, memory, or have a mental health condition that may affect their ability to participate
People who the study doctors decide are not suitable for the trial for other medical reasons (confirm with trial site)

⚠️ Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 2 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Hebei Medical University Fourth Hospital

Registry

ClinicalTrials.gov

Start date

15 May 2025

Est. completion

1 March 2032

Where this trial is recruiting

🇨🇳 China

Primary endpoints

5-year DFS Rate

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov